Renoprotective effect of SGLT-2 inhibitors among type 2 diabetes patients with different baseline kidney function: a multi-center study

BACKGROUND: To assess the effect of sodium glucose cotransporter-2 inhibitors (SGLT-2is) for type 2 diabetes on kidney outcomes stratified by patient baseline estimated glomerular filtration rate (eGFR) levels (i.e., eGFR ≤ 60, 60 < eGFR ≤ 90, and eGFR > 90 mL/min/1.73 m(2)). METHODS: Patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Fang-Ju, Wang, Chi-Chuan, Hsu, Chien-Ning, Yang, Chen-Yi, Wang, Chih-Yuan, Ou, Huang-Tz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499571/
https://www.ncbi.nlm.nih.gov/pubmed/34620182
http://dx.doi.org/10.1186/s12933-021-01396-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499571/
https://www.ncbi.nlm.nih.gov/pubmed/34620182
http://dx.doi.org/10.1186/s12933-021-01396-2

Ejemplares similares